Jay Kaminski work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Jay Kaminski personal email
Jay Kaminski phone numbers
Accomplished biopharmaceutical executive equally adept at shaping strategy, driving execution while nurturing culture. Proven leadership capability characterized by seasoned judgment, reasoned decision-making, strong collaboration skills and inspiring trust. Consistent track record of delivering results and exceeding objectives, with a demonstrated ability to attract, mentor and grow key talent. Passionate leader working with urgency to bring innovative therapeutics to enhance the lives of patients. Extensive leadership experience across:• Executive-level roles in strategic operations, in-line marketing and senior sales leadership• Global operations in complex and challenging business environments• Biologics, small molecules and cell therapeutics experience in Hematology, Oncology, Immunology, Urology, Gynecology, Gastroenterology, Rheumatology and Dermatology• All stages of product lifecycle: development - early commercialization – launch – growth – patent expiry• Deep experience with multiple and complex alliance partnerships and joint ventures
-
AdvisorKythera LabsSouth Carolina, United States -
AdvisorPrenosis Oct 2023 - PresentChicago, Illinois, United StatesThe company's mission is to address the significant gap in personalized treatment in the acute care setting with precision therapeutics guided by AI predictive diagnostics. Prenosis has developed the ImmunixTM Precision Medicine Platform which harnesses deep biological insights from a proprietary biobank matched with extensive clinical data, facilitating the development of precision therapeutics. Prenosis recently launched the Sepsis ImmunoScoreTM, the first FDA-approved AI diagnostic for Sepsis. -
Svp, Gm And AdvisorPancreatic Cancer Action Network Apr 2022 - PresentManhattan Beach, California, United States -
AdvisorSaama Sep 2018 - PresentSaama is an analytics innovator whose mission is to enable biotechnology and pharma clients access to previously unattainable, enterprise-level view of raw data across disparate business silos by leveraging and optimizing technologies, like deep learning and artificial intelligence. -
AdvisorNextec Neuroscience Jan 2023 - May 2023United StatesNexTec Neuroscience is a leading edge drug development company building a portfolio of drug+device therapeutics that utilize proprietary non-invasive low frequency focused ultrasound to safely open the blood-brain barrier and deliver targeted treatment in Neuro-Oncology and Neurodegenerative diseases.
-
AdvisorHealth2047 Inc. Aug 2019 - Dec 2020In partnership with the AMA, Health2047 is transforming healthcare at the system level. Health2047 is structured to harness Silicon Valley's disruptive approach to innovation by finding, forming, and scaling transformational companies in healthcare to address four areas: data liquidity, chronic care, radical productivity, and healthcare value. -
Chief Operating OfficerCelularity, Inc. May 2018 - Oct 2019Celularity is a clinical stage cell therapeutics company harnessing the unique biology of the placenta in the treatment of cancer, inflammatory and age-related diseases. -
Senior Vice President, Global Clinical Research And Development OperationsCelgene Jan 2016 - Apr 2018Summit, NjResponsible for leading Global Clinical R&D Operations functions in support of Celgene sponsored trials phase I through IV across all therapeutic areas (annually > 200 studies, > 6000 sites, > 25000 subjects, > 40 countries with 1000+ permanent and contract staff and an operational budget $130 M). Manage greater than $2B combined internal and external portfolio annually. -
Corporate Vice President, Global Clinical Research And Development OperationsCelgene May 2011 - Dec 2015Summit, NjChartered with developing and implementing new operating model for management of clinical trial design, execution and oversight for all Celgene sponsored trials globally from early stage drug development (phase I/II) through late stage (phase III/IV) and life cycle management across all therapeutic franchises.
-
Vice President, Business DevelopmentCelgene May 2010 - Apr 2011Summit, NjLead member of the Celgene Corporate BD Team responsible for the full array of business development activities including: In-licensing, Strategic Collaborations, M&A, Out-licensing, Alliance Management in support of building robust pipeline for short, mid and long-term corporate growth.
-
Vice President, General Manager Celgene Cellular TherapeuticsCelgene Jan 2003 - Apr 2010VP, GM responsible for developing business plan, strategic direction, operational execution with full P&L for Celgene Cellular Therapeutics (CCT), (formerly Anthrogenesis, acquired in 2003) through acquisition of start-up cell therapy company which operated as a wholly owned division of Celgene Corporation.
-
Vice President, Strategic OperationsCelgene Feb 2002 - Dec 2002Led design, development and implementation of the Enhanced S.T.E.P.S. (REMS) managed distribution program in support of THALOMID (thalidomide) and REVLIMID (lenalidomide) commercialization and successor compounds which Celgene (now BMS) and the industry at large distribute therapeutics through REMS programs. Patents: US6315720, US6561977, US7655784, US6869399, US7141018, US7959566. Responsibilities also included new business development activities.
-
Executive Director, Sales And Commercial OperationsCelgene Feb 2000 - Jan 2002Responsible for sales, commercial operations, customer service, warehousing and distribution, contracting, pricing, government affairs for commercial products (THALOMID, thalidomide and ALKERAN, melphalan).
-
Director Of Field SalesCelgene Mar 1997 - Jan 2000Recruited to build sales and commercial operations group for emerging biotech company in support of first approved product (THALOMID, thalidomide).
-
Group Marketing ManagerTap Pharmaceuticals May 1990 - Mar 1997Greater Chicago AreaA joint venture between Abbott Labs and Takeda Pharmaceutical which experienced peak sales exceeding $3B. Responsible for brand management and in-line marketing for Lupron (leuprolide acetate for depot suspension) in urology, oncology, gynecology and Prevacid (lansoprazole) in gastroenterology for managed care markets. Prevacid brand team member for worldwide launch of second marketed proton pump inhibitor.
Jay Kaminski Skills
Jay Kaminski Education Details
-
Business, Management, Marketing, And Related Support Services
Frequently Asked Questions about Jay Kaminski
What company does Jay Kaminski work for?
Jay Kaminski works for Kythera Labs
What is Jay Kaminski's role at the current company?
Jay Kaminski's current role is Advisor.
What is Jay Kaminski's email address?
Jay Kaminski's email address is ja****@****047.com
What is Jay Kaminski's direct phone number?
Jay Kaminski's direct phone number is +190867*****
What schools did Jay Kaminski attend?
Jay Kaminski attended Ithaca College.
What skills is Jay Kaminski known for?
Jay Kaminski has skills like Pharmaceutical Industry, Biotechnology, Clinical Trials, Clinical Development, Business Strategy, Strategic Partnerships, Lifesciences, Long Range Planning, Finance.
Not the Jay Kaminski you were looking for?
-
-
-
3gmail.com, alcovamortgage.com, sierrapacificmortgage.com -
1myway.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial